CBLL CeriBell, Inc.
USHealthcareAs of 2026-10-09
Why CBLL matters now
CeriBell, Inc. (CBLL) is a US stock in Healthcare. The latest InvestLog snapshot shows $23.63 with +2.07% on the session and $896.6M in market capitalization; recent performance reads 1-month +6.31% and YTD -17.78%.
The latest financial table shown here is Q1 2026, with revenue of $26.5M, net income of $-19.7M, and EPS of $-0.52. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -7.2%.
The latest indexable market news headline is "Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $25.00; recent insider activity includes Taylor Joseph Michael filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.82
P/S
7.20
EV/EBITDA
-11.54
DCF Value
$-46.67
FCF Yield
-7.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.7%
Operating Margin
-68.3%
Net Margin
-63.5%
ROE
-38.2%
ROA
-33.9%
ROIC
-39.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $26.5M | $-19.7M | $-0.52 |
| Q4 2025 | $24.8M | $-13.5M | $-0.36 |
| FY 2025 | $89.1M | $-53.4M | $-1.46 |
| Q3 2025 | $22.6M | $-13.5M | $-0.37 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$25.00
Target (Median)
$25.00
Target Range
$25.00 - $25.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.84
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.